A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia [EXTENSION OF 700239254]

Trial Profile

A Phase III, Open-Label Extension Trial of the Safety and Efficacy of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia [EXTENSION OF 700239254]

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Ferumoxytol (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Sponsors AMAG Pharmaceuticals
  • Most Recent Events

    • 23 Apr 2014 The trial has been terminated as per Clinical Trials Registry - India record and M.D. Anderson Cancer Center record.
    • 23 Apr 2014 New source identified and integrated, M.D. Anderson Cancer Center record (2010-0436).
    • 23 Apr 2014 New source identified and integrated, Clinical Trials Registry - India (CTRI2010-091-001462).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top